Dual Bronchodilators No Help for Symptomatic Smokers With Preserved Lung Function
(MedPage Today) -- Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in former or current smokers with preserved lung function, the RETHINC trial showed. Among 535 symptomatic smokers with a 10 pack-year history and preserved... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 4, 2022 Category: Allergy & Immunology Source Type: news

A Legacy of the Deepwater Horizon Spill: Asthma in Cleanup Workers
(MedPage Today) -- Workers who responded to the Deepwater Horizon oil spill in 2010 were more likely to report incident asthma within a few years, a cohort study found. Those oil spill response and cleanup workers were 60% more likely to report... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 20, 2022 Category: Allergy & Immunology Source Type: news

Smaller Airways Set the Stage for Worse COPD Outcomes in Women
(MedPage Today) -- Smaller airways in women may explain their worse respiratory outcomes in chronic obstructive pulmonary disease (COPD), a large cohort study suggested. For never-smokers and ever-smokers alike, CT imaging revealed that men had... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 2, 2022 Category: Allergy & Immunology Source Type: news

Make the Diagnosis: Several Possible Culprits …
(MedPage Today) -- (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - July 28, 2022 Category: Allergy & Immunology Source Type: news

First Treatment Approved for Eosinophilic Esophagitis
(MedPage Today) -- Dupilumab (Dupixent) became the first drug approved to treat eosinophilic esophagitis in adults and pediatric patients ages 12 and older weighing at least 40 kg (~88 lb), the FDA announced. Eosinophilic esophagitis is a chronic... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 21, 2022 Category: Allergy & Immunology Source Type: news

Five Core Principles to Empower Our Patients
(MedPage Today) -- The COVID-19 pandemic was a double-edged sword for patient engagement. For some, the inability to access traditional, brick-and-mortar healthcare opened their minds to virtual solutions and helped them get more acutely involved... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 20, 2022 Category: Allergy & Immunology Source Type: news

Vulnerable Teens May Ask, Who'll Stop the Rain?
(MedPage Today) -- SAN FRANCISCO -- Ordinary adolescents showed higher levels of a biomarker for airway inflammation in the days following rain or snow, researchers reported here. For every 2 mm/day of precipitation averaged over the previous... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 19, 2022 Category: Allergy & Immunology Source Type: news

Triple Therapy for COPD: One Drug Too Many, Too Often?
(MedPage Today) -- SAN FRANCISCO -- Patients with chronic obstructive pulmonary disease (COPD) who changed treatment from so-called triple therapy to a two-drug product omitting the inhaled corticosteroid (ICS) component tended to see improved... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 19, 2022 Category: Allergy & Immunology Source Type: news

Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down
(MedPage Today) -- SAN FRANCISCO -- For neighborhoods near a major coking operation in Pittsburgh, its shutdown at the end of 2015 was followed by markedly lower rates of respiratory disease hospitalizations, researchers reported here. Inpatient... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 18, 2022 Category: Allergy & Immunology Source Type: news

Two Drugs Better Than One for 'Rescue' Asthma Therapy
(MedPage Today) -- SAN FRANCISCO -- Phase III results look very good for a two-drug combination inhaler in helping asthma patients regain symptom control when maintenance medications weren't doing the job. In the MANDALA trial, patients using... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 15, 2022 Category: Allergy & Immunology Source Type: news

ECMO for COVID; Heart Attack Treatment in High-Income Countries; Screen for COPD?
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 14, 2022 Category: Allergy & Immunology Source Type: news

Prenatal Disinfectant Exposure Linked to Asthma Risk in Kids
(MedPage Today) -- Mothers who were exposed to disinfectants on the job were more likely to have children with asthma, an analysis of a large birth cohort from Japan suggested. After adjusting for many factors including maternal return to work... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - April 20, 2022 Category: Allergy & Immunology Source Type: news

Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults
(MedPage Today) -- While the risk of anaphylaxis after administration of IV iron product was low among older adults, it was more common after certain iron products, researchers found. The highest adjusted incidence rates for anaphylaxis among... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 28, 2022 Category: Allergy & Immunology Source Type: news

Nasal Spray Flu Vaccine No Problem for Kids With Asthma
(MedPage Today) -- The intranasal live attenuated flu vaccine is just as safe for children with asthma as the intramuscular inactivated vaccine, a small clinical trial suggested. Within 42 days of vaccination, 10.8% of children who received the... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 28, 2022 Category: Allergy & Immunology Source Type: news

Military Exposure to Burn Pits Under Scrutiny
(MedPage Today) -- Doctors, scientists, and patient advocates described the tremendous harms of burn pits to active duty service members and veterans, ranging from cancers to severe respiratory illness and death, during a hearing of the Senate... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 17, 2022 Category: Allergy & Immunology Source Type: news